Novartis backs new biotech research
Novartis, the Swiss pharmaceuticals company, made a substantial move into proteomics, a fast-growing field of biology research. It announced a $84m investment and research deal with Geneva
Novartis, the Swiss pharmaceuticals company, made a substantial move into proteomics, a fast-growing field of biology research. It announced a $84m investment and research deal with Geneva